Literature DB >> 17296508

Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management.

S Halimi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17296508     DOI： 10.1016/S1262-3636(07)70309-9

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN： 1262-3636            Impact factor:   6.041


× No keyword cloud information.
  12 in total

Review 1.  Cardiovascular impact of drugs used in the treatment of diabetes.

Authors:  Chris R Triggle; Hong Ding
Journal:  Ther Adv Chronic Dis       Date:  2014-11       Impact factor: 5.091

2.  Mitochondrial Dysfunction: Metabolic Drivers of Pulmonary Hypertension.

Authors:  Hagir B Suliman; Eva Nozik-Grayck
Journal:  Antioxid Redox Signal       Date:  2019-02-25       Impact factor: 8.401

3.  Metformin activates AMP kinase through inhibition of AMP deaminase.

Authors:  Jiangyong Ouyang; Rahulkumar A Parakhia; Raymond S Ochs
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

Review 4.  Mitochondrial biogenesis: regulation by endogenous gases during inflammation and organ stress.

Authors:  Hagir B Suliman; Claude A Piantadosi
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

5.  Decreased efficacy of the ketamine and scopolamine-induced sustained antidepressant-like effects in rats receiving metformin.

Authors:  Han-Wen Chuang; I-Hua Wei; Chun-Te Li; Chih-Chia Huang
Journal:  Pharmacol Rep       Date:  2021-11-30       Impact factor: 3.024

6.  Two weeks of metformin treatment enhances mitochondrial respiration in skeletal muscle of AMPK kinase dead but not wild type mice.

Authors:  Jonas M Kristensen; Steen Larsen; Jørn W Helge; Flemming Dela; Jørgen F P Wojtaszewski
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

Review 7.  Evidence to support the use of vildagliptin monotherapy in the treatment of type 2 diabetes mellitus.

Authors:  Sylvie Dejager; Anja Schweizer; James E Foley
Journal:  Vasc Health Risk Manag       Date:  2012-05-18

8.  Efficacy and tolerability of vildagliptin as first line treatment in patients with diabetes type 2 in an outpatient setting.

Authors:  M P Yavropoulou; M Pikilidou; K Kotsa; A Michopoulos; E Papakonstantinou; J G Yovos
Journal:  J Diabetes Metab Disord       Date:  2015-08-22

Review 9.  Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium.

Authors:  Mustafa Kinaan; Hong Ding; Chris R Triggle
Journal:  Med Princ Pract       Date:  2015-05-28       Impact factor: 1.927

Review 10.  Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet.

Authors:  Serge Halimi; Anja Schweizer; Biljana Minic; James Foley; Sylvie Dejager
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.